PCR adjusted Outcome | Artesunate–amodiaquine | Artemether–lumefantrine | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Bensonville (n = 91) | Saclepea (n = 89) | Overall (n = 180) | Kakata (N = 89) | Sinje (N = 90) | Overall (n = 179) | |||||
n (%) | CI 95% | n (%) | 95% CI | % (CI 95%) | n (%) | CI 95% | n (%) | 95% CI | % (CI 95%) | |
LCFa | 0 | 0.0–7.1 | 2 (2.4) | 0.3–8.5 | 1.5 (0.2–5.3) | 0 | 0.0–4.6 | 0 (0) | 0.0–4.1 | 0 (0.0–2.2 |
LPFb | 5 (9.8) | 3.3–21.4 | 4 (4.9) | 1.3 | 7.5 (3.6–13.3) | 0 | 0.0–4.6 | 0 (0) | 0.0–4.1 | 0 (0.0–2.2 |
ACPRc | 46 (90.2) | 78.6–96.7 | 76 (92.7) | 84.8–97.3 | 91.0 (84.9–95.3) | 79 (100) | 95.4–100 | 88 (100) | 95.9–100 | 100 (97.8–100) |
Total per-protocol | 51 | 82 | 134 | 79 | 88 | 167 | ||||
Withdrawn/lost: | 19 (20.9) | 1 (1.1) | 20 (11.1) | 5 (5.6) | 2 (2.2) | 7 (3.9) | ||||
Re-infection | 20 (23.1) | 5 (5.6) | 25 (13.9) | 5 (5.6) | 0 | 5 | ||||
Unknown | 1 (1.1) | 0 | 1 (0.6) | 0 | 0 | 0 | ||||
KMd cure rate | 92.1 | 81.9–96.6 | 93.0 | 85.1–96.8 | 92.0 (86.4–95.4) | 100 | NA | 100 | NA | 100 (NA) |